Caplin Deirdre A, Rao Jaya K, Filloux Francis, Bale James F, Van Orman Colin
Department of Pediatrics, Division of General Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA.
Epilepsia. 2006 Dec;47(12):2011-9. doi: 10.1111/j.1528-1167.2006.00853.x.
To use available evidence and expert consensus to develop performance indicators for the evaluation and management of pediatric epilepsy.
We used a three-step process to develop the performance indicators. First, research findings were compiled into evidence tables focusing on different clinical issues. Second, an advisory panel of clinicians, educational and public health experts, and families of children with epilepsy reviewed the evidence. The advisory group used the evidence to draft a preliminary set of performance indicators for pediatric epilepsy management. Third, 13 internationally recognized experts in pediatric neurology or epilepsy rated the value of these indicators on a 5-point scale [1 (essential) to 5 (not necessary)] in a two-round Delphi process. Positive consensus was reached if >or=80% of experts gave an indicator a "1" rating and negative consensus if >80% gave an indicator a "5" rating. Indicators that achieved positive consensus during either round of the Delphi process constituted the final set of indicators.
Of the 68 draft performance indicators, the expert panel members achieved positive consensus on 30 performance indicators: eight indicators related to diagnostic strategies and seizure classification, nine related to antiepileptic drug use, six related to cognitive and behavioral issues, six related to quality of life, and three related to specialty referrals.
We identified 30 potential indicators for evaluating the care provided to pediatric patients with epilepsy. The next step is to examine the relation of these performance indicators to clinical outcomes and health care utilization among pediatric patients with epilepsy.
利用现有证据和专家共识制定用于评估和管理小儿癫痫的性能指标。
我们采用三步法来制定性能指标。首先,将研究结果汇编成聚焦于不同临床问题的证据表。其次,由临床医生、教育和公共卫生专家以及癫痫患儿家属组成的咨询小组对证据进行审查。该咨询小组利用这些证据起草了一套小儿癫痫管理性能指标的初稿。第三,13位国际公认的小儿神经学或癫痫领域专家在两轮德尔菲法过程中,以5分制[1(必要)至5(不必要)]对这些指标的价值进行评分。如果≥80%的专家将某一指标评为“1”,则达成积极共识;如果>80%的专家将某一指标评为“5”,则达成消极共识。在德尔菲法过程的任何一轮中达成积极共识的指标构成最终指标集。
在68项性能指标草案中,专家小组成员对30项性能指标达成了积极共识:八项指标与诊断策略和癫痫发作分类有关,九项与抗癫痫药物使用有关,六项与认知和行为问题有关,六项与生活质量有关,三项与专科转诊有关。
我们确定了30项潜在指标,用于评估为小儿癫痫患者提供的护理。下一步是研究这些性能指标与小儿癫痫患者临床结局和医疗保健利用之间的关系。